1. Introduction {#SC001}
===============

One of the main identifiable causes of male infertility is varicocele caused by veins dilatation of of the pampiniform plexus of the spermatic cord in the scrotum ([@R001]). Varicocele is a progressive lesion that usually occurs in the left testicle ([@R002]).

The prevalence of this disorder is about 15--20% among the general population ([@R003]). Despite all evidence, including alteration in testicular histology and normal function of Sertoli and Leydig cells and also changes in semen parameters that occur as a result of varicocele ([@R004], [@R005]), there is still a debate about the direct mechanism responsible for the impact of varicocele on spermatogenesis and male fertility potential ([@R006]--[@R009]).

One of the important factors in the process of fertilization and normal development of the embryo is sperm DNA integrity ([@R010]). Several studies have shown that infertile men compared with fertile men display higher levels of sperm DNA damages ([@R011]--[@R015]).

During spermiogenesis, the sperm nucleus will undergo a major rearrangement, in which the histones are replaced by positively charged protamines (PRMs). The replacement of histones by PRMs in sperm DNA is supported by other proteins such as transition nuclear proteins (TNPs) ([@R016], [@R017]). This event makes sperm DNA highly condensed and protects the sperm genome integrity that is important for normal sperm function and fertility ([@R018], [@R019]).

*TNP2* gene is located on human chromosome 16p13.3 ([@R020], [@R021]). The pathogenic mutations in the *PRM* and *TNP* genes could be one of the reasons for these altered levels ([@R019]). Several studies have demonstrated that in men with varicocele, the sperm DNA integrity is significantly reduced and also the amount of DNA damage is increased compared with healthy controls ([@R012], [@R013], [@R022]).

Therefore, because of the critical role of TNPs and PRMs in sperm DNA integrity, these proteins could be one of the best goals for study in varicocele condition. So in this study, we decided to analyze the *TNP2* gene mutations in Iranian infertile varicocele patients.

2. Material & Methods {#SC002}
=====================

2.1. Participants {#SC003}
-----------------

This study was a case-control study. The study included 156 Iranian infertile males with varicocele and a history of infertility of ≥ 2 yr. The healthy donors included 150 fertile Iranian men who had a successful pregnancy, and normal spermogram.

The varicocele diagnosis and blood sample collection were performed by the urologist from 2011 to 2015. Semen analysis was performed according to the WHO criteria ([@R023]). Sperm parameters are listed in Table [I](#T001){ref-type="table"} that include sperm count, rapid (grade a), slow (grade b), and non-progressive (grade c) motility, and sperm morphology. The mean age of infertile men with varicocele and normal controls was 28.3░±░5.63 and 29.7░±░6.14 (Mean░±░SD), respectively, and were match to each other.

###### 

Mean and standard deviation of sperm parameters of patients and participants of the variants, SIFT and PolyPhen (sequence homology-based tools) were used.

  Variables                                 Varicocele (n░=░156)   Control (n░=░150)   P-value^\*^
  ----------------------------------------- ---------------------- ------------------- -------------
  Age                                       28.3░±░5.63            29.7░±░6.14         0.790
  Count (mil.ml^-1^)                        46.20░±░44.29          106.20░±░58.39      0.000
  Rapid motility (%) or grade a             11.03░±░9.72           26.32░±░6.89        0.000
  Slow motility (%) or grade b              32.01░±░8.14           29.12░±░3.68        0.615
  Non-progressive motility (%) or Grade c   17.56░±░8.32           10.41░±░3.01        ≤ 0.001
  Normal morphology (%)                     26.80░±░15.35          41.98░±░8.13        ≤ 0.001

Differences between variables with normal distribution were analyzed the Chi-square goodness-of-fit test

Peripheral Blood samples of patient and control groups were collected in EDTA-coated tubes in the Research and Clinical Center for Infertility, Shahid Sadoughi University of Medical Sciences, Yazd, Iran and were stored at -20░°C until analysis.

2.2. Semen analysis {#SC004}
-------------------

Semen samples collection were performed by masturbation after 2--4 days of sexual abstinence. Semen analysis was completed according to the guidelines of the WHO criteria (World Health Organization, 1999) and Diff quick staining was applied for sperm morphology score ([@R024], [@R025]). Azoospermic samples were excluded from the study. Normal values were sperm motility ≥ 50% (a░+░b), sperm concentration ≥ 20  × 106 per ml, and normal sperm forms \> 30%.

2.3. The assessment of sperm nuclear chromatin {#SC005}
----------------------------------------------

Three techniques of cytochemical staining were used for sperm nuclear chromatin evaluation. For distinguishing the anomalies of sperm chromatin condensation, aniline blue was used according to Auger et al. Briefly, air-dried smears of fresh semen samples of a patient fixed in glutaraldehyde and phosphate buffer at room temperature were then stained with aqueous AB stain in acetic acid. Then stained and unstained spermatozoa were evaluated by light microscopy (Olampus, Tokyo, Japan).

The rate of sperm nuclear chromatin condensation was measured via toluidine blue (TB) staining ([@R001]). In this procedure, air-dried sperm smears were fixed in fresh ethanol-acetone and then hydrolyzed in HCl. Then the samples were rinsed in distilled H~2~O and finally stained with TB. The scores of chromatin quality of spermatozoa according to this procedure, included 0, good chromatin; 1, mild abnormal chromatin; 2, severe chromatin abnormality ([@R001]). So, spermatozoa with scores 1 and 2 were considered as TB░+░or abnormal chromatin, score 0 as a TB- or spermatozoa with normal chromatin.

In situ acid-induced denaturation of sperm nuclear DNA were measured by Acridine Orange (AO) staining. In this staining, air-dried sperm smears were fixed in Carnoy's solution and then each sample was stained in AO. Samples were evaluated on the fluorescent microscope. The green (normal double-stranded DNA) and orange/red (abnormally denatured DNA) fluorescence spermatozoa percentage were calculated according to the recommended method provided by Talebi et al ([@R015]).

2.4. Mutation screening of *TNP2* gene {#SC006}
--------------------------------------

Genomic DNA was extracted from the blood samples with DNA extraction kit (CinnaClone, Tehran, Iran). Two PCR primer sets were designed and optimized by using the software Gene Runner version 3.05 (Hastings Software, Hastings, NY, USA) to proliferate the two exons of *TNP2* gene (Table [II](#T002){ref-type="table"}). PCR amplification was carried out at 94░°C for 5░min, followed by 35 cycles of denaturation at 94░°C for 30░sec, annealing at 61░°C (Exon 1) and 62░°C (Exon 2) for 40░sec, and extension at 72░°C for 40░sec, followed by a final extension for 5░min. PCR of each sample was set in a 0.5░ml tube using 100░ng of total DNA, 10░pM of each primer, 200░μM of dNTPs, 1X PCR buffer containing 2.5░mM MgCl2, and 1 U Taq DNA polymerase (CinnaClone, Tehran, Iran).

###### 

Primers used for amplification with PCR

  Primer sequence (5\'-3\')             Primer size (bp)   Exon   Amplicon size (bp)
  ------------------------------------- ------------------ ------ --------------------
  *F1*: AGC CTT CCT ATC ACC CAC AC      20                 1      440
  *R1*: GGT CTG CTC TCC ATC ATC TG      20                        
  *F2*: TAC AGG AGG TCA AGG AGG TCA C   22                 2      127
  *R2*: ACA CGC AGG AAC AAG CCA AG      20                        

Single strand conformation polymorphism (SSCP) technique was used to analyse the unknown mutations because it\'s a simple and sensitive procedure ([@R026]). All PCR products from cases and controls were analyzed by SSCP. For the SSCP analysis, 5░μl of the PCR products were mixed with 10░μl of SSCP loading buffer. The samples were denatured at 95░°C for 5░min and then rapidly cooled on ice to prevent renaturation; 10░μl of this mixture was loaded onto the polyacrylamide gels. The PCR products of exon 1 with a size of 440 bp was loaded onto 8% (w/v) polyacrylamide gel for 22░hr at 100░V and 14░mA, and the PCR products relating to exon 2 with a size of 127 bp were loaded onto 10% (w/v) polyacrylamide gel for 15░hours at 110░V and 16░mA. The gels were stained using the standard silver staining procedure to reveal the bands of single-strand DNA, and then the gels were wrapped in cellophane for preservation. Direct sequencing of DNA from samples with altered band pattern in the SSCP was done by a commercial agency (Macrogene Seoul, South Korea) to identify mutations.

2.5. Bioinformatics analysis {#SC007}
----------------------------

The MEGA4 software was used for multiple sequence alignment to find the amount of homology of the sequences that have been obtained in the study and with all other sequences of the other species. As the structure of human transition protein 2 (TP2) has not yet been solved, the homology-based structural prediction service Protein Model Portal (<http://www.proteinmodelportal.org/>) ([@R027]) was used to generate the structure by submitting the human TP2 sequence (UniProt: Q05952). Using PyMol software, the effect of altered residue in the protein structure was evaluated. Also, to determine the pathogenicity of the variants, SIFT and PolyPhen (sequence homology-based tools) were used.

2.6. Ethical consideration {#SC008}
--------------------------

The ethics committee of the Biology Department of Yazd University approved all the plans and protocols of this study and each participant was fully informed of the objectives and content of it.

2.7. Statistical analysis {#SC009}
-------------------------

The *TNP2* gene SNPs were included in three genotype categories (wild-type, heterozygote, and homozygote SNPs) and then grouped into two categories with heterozygotes and homozygote variants combined because of the dominant, the recessive, and the over-dominant models of inheritance observed for these polymorphisms.

In order to clarify the relationship between the two study groups, we used the Chi-square goodness-of-fit test, and the values of p░\<░0.05 were regarded as statistically significant. Also, a Chi-square test was performed for determining if the case and control groups demonstrate Hardy-Weinberg equilibrium. Odds ratio (OR) was calculated to measure the strength of the association observed. Multiple logistic regression analysis models were used to evaluate the haplotypes as possible risk factors. This statistical analysis was performed by SPSS (Statistical Package for the Social Sciences, version 20, SPSS Inc., Chicago, IL, USA).

3. Results {#SC010}
==========

The results of aniline blue staining show that AB-reacted spermatozoa (AB+) rates in varicocele and control groups were significant (p░≤░0.001). With regard to the AO test, DNA damage in sperm nuclei from infertile men with varicocele was a significant difference control group (p░=░0.001). Also, the results of TB staining showed a significant difference between control and varicocele groups (p░≤░0.001).

After the amplification of DNA fragments that isolated from blood samples of 156 patients and 150 controls using PCR and then SSCP procedures, some altered conformation patterns were detected by the SSCP analysis for the fragments of exons 1 & 2 of the *TNP2* gene. Finally, the samples of these altered conformation patterns were sequenced (Figure [1](#F001){ref-type="fig"}). The results of sequencing showed three variants at positions g.IVS1-26 G░\>░C (rs8043625), c.301C░\>░T (rs34904070), and c.391C░\>░T (rs11640138) of this gene. c.301C░\>░T mutation changes the Arginine to Cysteine at position 101 (p.R101C) and c.391C░\>░T changes the Arginine to Tryptophan at position 131 (p.R131░W) of TP2 protein.

![(A) The SSCP patterns of exon 2 of *TNP2* gene. (B) The results of direct sequencing of exon 2 of *TNP2* gene revealed g.IVS1-26G░\>░C (rs8043625). Lanes 3, 4, and 6 show G/G, C/C, and C/G genotypes, respectively. Also, lanes 1, 2, and 5 have G/G genotype and lane 7 similar to lane 6 has C/G.](ijrb-17-557-g001){#F001}

Genotype distribution in the control group for the all polymorphisms was in Hardy-Weinberg equilibrium. No significant differences were observed in genotype and allele frequencies of c.301C░\>░T and c.391C░\>░T variants. The distribution of genotype frequencies between Varicocele patients and controls wasn't statistically significant, differences neither in the co-dominant nor in the dominant and recessive models (Tables III and IV). But for g.IVS1-26G░\>░C SNP, the genotype frequencies of the G/G, G/C, and C/C were as 25.6%, 44.9%, and 29.5%, respectively, in cases and 50.7%, 37.3%, and 12%, respectively, in controls. The logistic regression analysis showed a significant association of the g.IVS1-26G░\>░C SNP and Varicocele according to the dominant, recessive, and over-dominant models (dominant model OR: 2.98, 95% CI: 1.84--4.82; p░=░0.000, recessive model OR: 3.07, 95%CI: 1.68--5.59); p░=░0.000, and over-dominant model OR: 1.37, 95% CI: 0.86--2.16; p░≤░0.001) (Table [V](#T005){ref-type="table"}).

###### 

Genotype distribution and relative allele frequencies of rs34904070 (c.301C░\>░T) polymorphism in the *TNP2* gene among Varicocele and control group

  rs34904070 (c.301C░\>░T)   Patients (n░=░156)   Controls (n░=░150)   OR (95% CI)            P-value
  -------------------------- -------------------- -------------------- ---------------------- ---------
  Codominant model                                                                            
  CC                         78 (50%)             84 (56%)             1 (ref.)               
  CT                         66 (42%)             60 (40%)             1.10 (0775--1.560)     0.593
  TT                         12 (7.7%)            6 (4%)               2.00 (0.571--5.329)    0.166
  Dominant model                                                                              
  CC                         78 (50%)             84 (56%)             1 (ref.)               0.293
  CT░+░TT                    78 (50%)             66 (44%)             1.27 (0.81--2.00)      
  Recessive model                                                                             
  CC░+░CT                    144 (92.3%)          144 (96%)            1 (ref.)               0.165
  TT                         12 (7.7%)            6 (4%)               2.00 (0.73--5.47)      
  Over-dominant model                                                                         
  CC░+░TT                    90 (57.7%)           90 (60%)             1 (ref.)               0.681
  CT                         66 (42.3%)           60 (40%)             1.10 (0.70--1.73)      
  Allele frequency                                                                            
  C                          228 (76%)            222 (71.15%)                                
  T                          72 (24%)             90 (28.85%)          0.779 (0.543--1.117)   0.199

P-value by Chi-square goodness-of-fit test

###### 

Genotype distribution and relative allele frequencies of rs11640138 (c.391░T░\>░C) polymorphism in the *TNP2* gene among Varicocele and control group

  rs11640138 (c.391░T░\>░C)   Patients (n░=░156)   Controls (n░=░150)   OR (95% CI)            P-value
  --------------------------- -------------------- -------------------- ---------------------- ---------
  Codominant model                                                                             
  TT                          54 (34.6%)           60 (40%)             1 (ref.)               
  CT                          70 (44.9%)           64 (42.7%)           1.094 (0.779--1.535)   0.604
  CC                          32 (20.5%)           26 (17.3%)           1.231 (0.734--2.065)   0.432
  Dominant model                                                                               
  TT                          54 (34.6%)           60 (40%)             1 (ref.)               
  CT░+░CC                     102 (65.4%)          90 (60%)             1.26 (0.79--2.00)      0.330
  Recessive model                                                                              
  TT░+░CT                     124 (79.5%)          124 (82.7%)          1 (ref.)               
  CC                          32 (20.5%)           26 (13.3%)           1.23 (0.69--2.19)      0.477
  Over-dominant model                                                                          
  TT░+░CC                     86 (55.1%)           86 (57.3%)           1 (ref.)               
  CT                          70 (44.9%)           64 (42.7%)           1.09 (0.70--1.72)      0.697
  Allele frequency                                                                             
  T                           184 (61.33%)         178 (57.05%)                                
  C                           116 (38.67%)         134 (42.95%)         0.837 (0.606--1.157)   0.286

P-value by Chi-square goodness-of-fit test

###### 

Genotype distribution and relative allele frequencies of rs8043625 (g.IVS1-26G░\>░C) polymorphism in the *TNP2* gene among Varicocele and control group

  rs8043625 (g.IVS1-26G░\>░C)   Patients (n░=░156)   Controls (n░=░150)   OR (95% CI)            P-value
  ----------------------------- -------------------- -------------------- ---------------------- ----------------
  Codominant model                                                                               
  GG                            40 (25.6%)           76 (50.7%)           1 (ref.)               
  GC                            70 (44.9%)           56 (37.3%)           1.250 (0.880--1.776)   0.213
  CC                            46 (29.5%)           18 (12.0%)           2.556 (1.482--4.407)   0.001
  Dominant model                                                                                 
  GG                            40 (25.6%)           76 (50.7%)           1 (ref.)               
  GC░+░CC                       116 (74.4%)          74 (49.3%)           2.98 (1.84--4.82)      0.000
  Recessive model                                                                                
  GG░+░GC                       110 (70.5%)          132 (88.0%)          1 (ref.)               
  CC                            46 (29.5%)           18 (12.0%)           3.07 (1.68--5.59)      0.000
  Over-dominant model                                                                            
  GG░+░CC                       86 (55.1%)           94 (62.7%)           1 (ref.)               
  GC                            70 (44.9%)           56 (37.3%)           1.37 (0.86--2.16)      0.000
  Allele frequency                                                                               
  G                             208 (69.30%)         150 (48.1%)          2.442 (1.754--3.400)   p \< 0.001^\*^
  C                             92 (30.70%)          162 (51.9%)                                 

P-value by Chi-square goodness-of-fit test

Table [VI](#T006){ref-type="table"} shows the haplotype frequencies of three SNPs in two groups. The results of multiple logistic regression analyses revealed that the haplotypes (C/C/T) and (C/T/T) were a risk factor in patients with varicocele compared to controls (OR░=░3.278, p░≤░0.001, and OR░=░9.304, p░=░0.038, respectively).

###### 

Haplotype analysis of *TNP2* polymorphisms with Varicocele patients and in controls

  Haplotype   Patients (n░=░156)   Controls (n░=░150)   OR (95% CI)             P-value
  ----------- -------------------- -------------------- ----------------------- ---------
  G/C/T\*     79 (50.64)           105 (70.00)          1 (ref.)                
  G/C/C       21 (13.46)           22 (14.67)           1.269 (0.652--2.468)    0.483
  G/T/T       7 (4.49)             3 (2.00)             3.101 (0.777--12.372)   0.108
  G/T/C       3 (1.92)             2 (1.33)             1.994 (0.325--12.217)   0.455
  C/C/T       37 (23.72)           15 (10.00)           3.278 (1.682--6.389)    0.000
  C/C/C       7 (4.47)             2 (1.33)             9.878E-9 (0.000)        0.998
  C/T/T       1(0.64)              1 (0.67)             9.304 (1.122--77.165)   0.038
  C/T/C       1 (0.64)             0 (0.00)             \-                      \-

OR: Odds ratio; CI, Confidence interval

G/C/T haplotype were shown for g.IVS1-26G░\>░C/c.301C░\>░T/c.391░T░\>░C polymorphisms, respectively

P-value by Chi-square goodness-of-fit test

4. Discussion {#SC011}
=============

Recent studies showed a significant relationship between male infertility and reduced TP2 gene expressions ([@R028], [@R029]). During spermiogenesis, sperm nucleus are compacted, and for this reason, chromatin must be changed by the replacement of the common histones with PRMs (which are derived from histone H1) and TNPs ([@R030], [@R031]). Since nucleotide changes in the genes that code these nuclear proteins lead to male infertility in mice, it suggests that the replacement of the common histones with these nuclear proteins is the most important event during spermiogenesis ([@R005]). In the present study, to examine *TNP2* gene alterations in relation to human male infertility, we assessed the prevalence of *TNP* gene SNPs in infertile patients. Varicocele is one of the most common causes of seminal alteration ([@R006]). New studies support the hypothesis that the varicocele is a multifactorial disorder. There are many etiopathogenic factors that reveal this condition, but many etiologic and pathophysiologic aspects of this disorder need to be revealed ([@R032]). Our results of the evaluation of sperm nuclear chromatin showed that spermatozoa with abnormal DNA and immature chromatin in the varicocele patients were a higher proportion than those of the control group. Also, we found two reported missense mutations, including c.301C░\>░T (rs34904070) and c.391C░\>░T (rs11640138) in our patients. We report the non-significant difference in genotype and allele frequencies of these polymorphisms between an infertile man with varicocele and controls. The c.301C░\>░T and c.391C░\>░T mutations in *TNP2* gene previously have been described by Imken et al in infertile men by PCR and direct sequencing. Also, they did not find any significant association with the infertile phenotype ([@R033]).

Also, we identified the g.IVS1-26G░\>░C (rs8043625) in the intronic region of this gene in both cases and controls that showed a significant difference in incidences between the patient and the control group. Siasi et al studied the relationship between polymorphisms of *TNP2* gene with male infertility in 96 idiopathic infertile men with azoospermia or oligospermia and 100 normal control men in Iranian population. Their results show that the g.IVS1-26G░\>░C was not associated with male infertility ([@R034]). *Miyagawa et al* evaluated the mutations of *TNP1* and *TNP2* genes in male infertility in the Japanese population. In this study, more than 10 SNPs were found in these genes in which the prevalence g.IVS1-26G░\>░C in infertile males was not significantly different from that in fertile controls ([@R035]). However, biochemical analyses have proven that TNP2 increases the melting temperature of DNA and leads to DNA compacts to nucleosomal cores, which shows that it is a DNA-condensing protein ([@R036]). These analyses represent that this protein plays an important role in chromatin remodeling during spermiogenesis and for this reason, a few amino acid changes are tolerated in TNP2. However, the importance of TNP2 in human sperm formation is not fully understood. In our study, a three-dimensional structure model prediction of TP2 protein using the Protein Model Portal server has been made. The prediction of the tertiary structure of TP2 protein through in-silico analysis indicated that p.R101 and p.R131 are parts of a β strand located in a conserved region among several mammalian species (Figure [2](#F002){ref-type="fig"}). Predicted results of the pathogenicity of these variants with SIFT and PolyPhen tools are also summarized in Table [VII](#T007){ref-type="table"}. IVS1-26G░\>░C is a known single nucleotide polymorphism that was identified in the intronic region of this gene ([@R035]). *TNP2* sequence is poorly conserved during the evolution, and the levels of *TNP2* expression and its protein vary among species ([@R035]). But the g.IVS1-26G░\>░C polymorphism shows that they are conserved among other species and we also found a significant difference in the genotype and allele frequencies in patients with varicocele compared to controls. In addition, the haplotype analysis suggests combining genetic variations are associated with increased risk in patients with varicocele compared to controls (Table [VI](#T006){ref-type="table"}).

![A three-dimensional structure model prediction of TP2 protein using the Protein Model Portal server and showing a close-up of the R101 (A) and C101 residues (B), R131 (C) and W131 (D) using PyMol.](ijrb-17-557-g001){#F002}

###### 

Predicted results of the pathogenicity of rs34904070 (P.101 R░\>░C) and rs11640138 (P.131 R░\>░W) variants with SIFT and PolyPhen tools

  Predictor      Variation      Score                     Prediction
  -------------- -------------- ------------------------- -------------------------
  *SIFT*         P.101 R░\>░C   0.02                      AFFECT PROTEIN FUNCTION
  P.131 R░\>░W   0.00           AFFECT PROTEIN FUNCTION   
  *PolyPhen*     P.101 R░\>░C   0.096                     BENIGN
  P.131 R░\>░W   0.886          POSSIBLY DAMAGING         

5. Conclusion {#SC012}
=============

These findings indicate that this SNP (rs8043625) in varicocele patients may affect in intron splicing and may cause human male infertility in varicocele patients, but the exact molecular effects of this polymorphism on varicocele condition are still controversial. Next researches using linkage studies of SNPs in pedigrees and a larger population of infertile men should confirm the causal link between *TNP2* gene polymorphisms and male infertility.
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